Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Segal currently holds 3,633,844 shares of Protea Biosciences Group, Inc. (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Segal has been a net buyer of NONE stock. They have purchased $588.0K and sold $0 worth of shares.
Scott Segal's most recent insider trade was on Mar 24, 2017, when they sold 1,000,000 shares at $0.00 per share.
Scott Segal serves as Executive at Protea Biosciences Group, Inc. (NONE). They have executed 8 insider transactions totaling $588.0K over their tenure at the company.
Scott Segal holds the position of Executive at Protea Biosciences Group, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Scott Segal has shown a buying trading pattern, with $588.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Segal was on Jul 23, 2013, when they purchased $194.0K worth of NONE shares. This transaction involved 388,038 shares at $0.50 per share.
Scott Segal currently owns 3,633,844 shares of Protea Biosciences Group, Inc. (NONE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Segal's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Segal has 8 Form 4 filings on record as an insider at Protea Biosciences Group, Inc..
Set alerts for Scott Segal and 40,000+ other insiders.